Healthcare Through
a Different Lens.

AB International Health Care Portfolio


We believe it takes a disciplined approach focused on the health of the business to identify the most compelling opportunities in the rapidly evolving healthcare sector.


The healthcare sector offers investors an attractive investment proposition driven by its distinctive blend of defensive and growth characteristics.

Due to inelastic demand, many healthcare companies have inbuilt resilience, making the sector less susceptible to macroeconomic fluctuations.

Changes in global demographics and advancing technology are driving innovation and creating new opportunities.


Investing in Business–not Science

Our differentiated approach aims to harness the power of compounding within the healthcare sector for investors. We don’t believe in trying to predict scientific success – which is extremely hard to do. Instead, we focus our deep fundamental research on the underlying health of the businesses in which we invest. 

Our repeatable, proven process aims to benefit from the investible opportunities abound within the sector, balanced by a pragmatic and risk-aware approach to investment.

A Focus on Profitability and Reinvestment

Our concentrated portfolio targets high-quality businesses with a high and improving level of profitability, which enables companies to improve efficiency and reinvest back into the business to help drive long-term growth.

Healthy, High-Quality Businesses

High quality businesses with competitive advantages, high profitability and healthy balance sheets are better positioned to help deliver long-term growth in the rapidly changing healthcare environment.

Deep Research and Risk Management

Fundamental research, rooted in deep company and industry expertise, guides our active, stock selection process. Integrated risk management aims to ensure ample diversification, better risk-adjusted returns, and a smoother pattern of performance over time.


The value of an investment can go down as well as up and investors may not get back the full amount they invested. Capital is at risk.

Drivers of Growth Opportunities

Innovation in healthcare is redefining the sector’s business dynamics in areas such as:


A Focused Approach to Healthcare Companies

Lead Portfolio Manager, Vinay Thapar, explains how the team does things differently within their approach to stock analysis and selection.


Some of the principal risks of investing in the Portfolio include allocation risk, derivatives risk, emerging-markets risk, equity securities risk, focused portfolio risk, OTC derivatives counterparty risk and portfolio turnover risk. A full explanation of the risks is provided in the Portfolio’s Prospectus.


Meet Our Team

Lead portfolio manager Vinay Thapar and co-portfolio manager, John H. Fogarty, are supported by a dedicated team of research analysts offering deep experience and global perspectives.

Look at Healthcare Through a Different Lens

Against a backdrop of normalizing economic growth, innovation and strong profitability potential–coupled with favorable valuations–the healthcare sector could provide investors with a long-term durable growth opportunity and an attractive addition to an equity allocation.

Find Out More About the AB International Health Care Portfolio

Get in Touch

For more information, please contact us:


The Portfolio is meant as a vehicle for diversification and does not represent a complete investment program. Prospective investors should read the Prospectus, which includes Sustainability-Related Disclosures, and discuss risks and the Portfolio’s fees and charges with their financial advisor to determine if the investment is appropriate for them.

AB International Health Care Portfolio is a sub-fund of AB SICAV I, an open-ended investment company with variable capital (société d’investissement à capital variable) incorporated under the laws of the Grand Duchy of Luxembourg.

The sale of AB funds may be restricted or subject to adverse tax consequences in certain jurisdictions. This information is directed solely at persons in jurisdictions where the funds and relevant share class are registered or at those who may otherwise lawfully receive it. Before investing, investors should review the Fund’s full Prospectus, together with the Fund’s KIID or KID and the most recent financial statements. Copies of these documents, including the latest annual report and, if issued thereafter, the latest semiannual report, may be obtained free of charge from AllianceBernstein (Luxembourg) S.à r.l. by visiting or, or in printed form by contacting the local distributor in the jurisdictions in which the funds are authorised for distribution.

The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams and are subject to revision over time. There is no guarantee that any projection, forecast or opinion in this material will be realized.